First EU launch for Levemir in the UK

Article Abstract:

The comparative benefits of Novo Nordisk's Levemir (insulin determir), which has been introduced in United Kingdom (UK) market, for treating diabetes over other similar drugs produced by different companies have been discussed. The approval hurdles faced by Novo Nordisk's Levemir (insulin determir) in the United States and another diabetes drug developed by Novo Nordisk that is undergoing clinical trials has been described.

United Kingdom, Product introduction, New Products/Services, Drug therapy, Diabetes, Diabetes mellitus, Novo Nordisk Ltd., Novo Nordisk Levemir (Medication)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


How the industry operates

Article Abstract:

The growing demand for drugs despite rising prices and pharmaceutical industry's collaborations with biotechnology firms to develop novel drugs are discussed.

United States, Drugs, Growth, Biotechnology, Company growth

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Glossary

Article Abstract:

A glossary of terms and reference materials related to pharmaceuticals industry is presented.

Terminology, Glossary

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Pharmaceutical industry
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.